Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US weight loss centre starts using Tethys' diabetes risk score

This article was originally published in Clinica

Executive Summary

Structure House, a weight loss centre in Durham, North Carolina, has initiated a study using Tethys Bioscience's PreDx Diabetes Risk Score (DRS) on 50 participants in its 28-day programme. PreDx DRS is a blood test that measures a person's risk of developing diabetes within five years. Emeryville, California-based Tethys hopes that it will help doctors target preventative strategies, such as weight loss programmes, to the most at-risk individuals. The study will use PreDx DRS to assess whether Structure House's intensive lifestyle change programme can alter patients' probability of developing diabetes. It will also evaluate whether more specific feedback on diabetes risk at the start of the regimen will increase the subjects' motivation to change their lifestyle.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044083

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel